Cite
HARVARD Citation
Desai, A. et al. (2022). Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease. Cancer. 128 (15), pp. 2967-2977. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Desai, A. et al. (2022). Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease. Cancer. 128 (15), pp. 2967-2977. [Online].